Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

STRATA Skin Sciences (SSKN) Non Operating Income (2016 - 2025)

STRATA Skin Sciences' Non Operating Income history spans 12 years, with the latest figure at $387000.0 for Q2 2024.

  • For Q2 2024, Non Operating Income rose 132.63% year-over-year to $387000.0; the TTM value through Jun 2024 reached -$975000.0, up 48.0%, while the annual FY2023 figure was -$2.3 million, 176.94% down from the prior year.
  • Non Operating Income for Q2 2024 was $387000.0 at STRATA Skin Sciences, up from -$479000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $2.0 million in Q2 2021 and bottomed at -$1.2 million in Q2 2023.
  • The 5-year median for Non Operating Income is -$198500.0 (2022), against an average of -$87666.7.
  • The largest YoY upside for Non Operating Income was 11261.11% in 2021 against a maximum downside of 2300.0% in 2021.
  • A 5-year view of Non Operating Income shows it stood at -$23000.0 in 2020, then crashed by 791.3% to -$205000.0 in 2021, then dropped by 12.68% to -$231000.0 in 2022, then tumbled by 92.64% to -$445000.0 in 2023, then soared by 186.97% to $387000.0 in 2024.
  • Per Business Quant, the three most recent readings for SSKN's Non Operating Income are $387000.0 (Q2 2024), -$479000.0 (Q1 2024), and -$445000.0 (Q4 2023).